| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | SC 13G/A 1 TOURMALINE BIO | Mar 15, 2024 | |
| SC 13G/A | Report | SC 13G/A 1 EFFECTOR THERAPEUTICS | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A ENLIVEN THERAPEUTICS | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G A AN2 | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A CELLECTIS | Feb 14, 2024 | |
| SC 13G/A | Report | SC 13G/A AKERO | Feb 14, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | Jan 29, 2024 | ||
| SC 13G/A | Report | Jan 26, 2024 | ||
| SC 13G | Report | SC 13G TOURMALINE BIO, INC. | Oct 27, 2023 | |
| SC 13G | Report | SC 13G CARIBOU BIOSCIENCES | Jul 10, 2023 | |
| SC 13G | Report | SC 13G ZURA BIO LIMITED | Mar 30, 2023 | |
| SC 13G/A | Report | SC 13G A 2 PYXIS ONCOLOGY | Mar 23, 2023 | |
| SC 13G/A | Report | SC 13G/A PYXIS ONCOLOGY | Feb 13, 2023 | |
| SC 13G | Report | SC 13G AN2 THERAPEUTICS | Feb 13, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | Feb 7, 2023 | ||
| SC 13G/A | Report | Feb 3, 2023 | ||
| SC 13G | Report | SC 13G ORIC PHARMACEUTICALS | Dec 29, 2022 | |
| SC 13G | Report | SC 13G VALNEVA | Jun 29, 2022 | |
| SC 13G | Report | SC 13G AKERO THERAPEUTICS | Jun 28, 2022 | |
| SC 13G | Report | SC 13G EFFECTOR THEREAPEUTICS | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | SC 13G A 2 SPRINGWORKS | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A2 CONTRAFECT | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A ESSA PHARMA | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A BIOATLA | Feb 11, 2022 | |
| SC 13G | Report | SC 13G PYXIS ONCOLOGY | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A WAVE LIFE SCIENCE LTD | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A 4D MOLECULAR | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A 3 CORTEXYME | Feb 14, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | Feb 1, 2022 | ||
| SC 13G | Report | SC 13G CARDIFF ONCOLOGY INC. | Nov 19, 2021 | |
| SC 13G | Report | SC 13G ARVINAS, INC. | Sep 20, 2021 | |
| SC 13G | Report | SC 13G SPERO THERAPEUTICS, INC. | Jul 9, 2021 | |
| SC 13G/A | Report | CORTEXYME SC 13G/A 2 | Mar 25, 2021 | |
| SC 13G | Report | 4D MOLECULAR SC 13G | Feb 16, 2021 | |
| SC 13G | Report | BIOATLA SC 13G | Feb 16, 2021 | |
| SC 13G/A | Report | CONTRAFECT SC 13G/A | Feb 12, 2021 | |
| SC 13G/A | Report | SPRINGWORKS SC 13G/A | Feb 12, 2021 | |
| SC 13G | Report | Feb 12, 2021 | ||
| SC 13G/A | Report | SC 13G/A MORPHIC | Feb 12, 2021 | |
| SC 13G/A | Report | MERSANA THERAPEUTICS SC 13G/A | Feb 12, 2021 | |
| SC 13G/A | Report | CORTEXYME SC 13G/A | Feb 16, 2021 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2021 | |
| SC 13G/A | Report | Jan 29, 2021 | ||
| SC 13G | Report | SC 13G HOMOLOGY MEDICINES, INC. | Nov 19, 2020 | |
| SC 13G | Report | SC 13G ESSA PHARMA INC. | Aug 6, 2020 | |
| SC 13G | Report | SC 13G IMARA INC. | Mar 26, 2020 |